Is switching from Levemir (detemir) 19 units every night to Lantus (glargine) 19 units every night equivalent for an adult patient with diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Converting Levemir 19 Units to Lantus 19 Units

A 1:1 unit conversion from Levemir 19 units nightly to Lantus 19 units nightly is appropriate for most patients, though a 10-20% dose reduction should be considered for high-risk individuals. 1

Standard Conversion Protocol

For patients on once-daily Levemir, convert unit-for-unit to once-daily Lantus. 1 The American Diabetes Association supports this 1:1 conversion approach, as both insulin detemir (Levemir) and insulin glargine (Lantus) are long-acting basal insulin analogues with similar glycemic efficacy. 2

  • Clinical trial data demonstrates equivalent HbA1c lowering between glargine and detemir in both type 1 and type 2 diabetes. 3, 4
  • Both insulins achieve similar fasting plasma glucose control when dosed appropriately. 3

Critical Consideration: Twice-Daily Levemir Patients

If this patient was previously on twice-daily Levemir, sum both daily doses and reduce by 10-20% when converting to once-daily Lantus. 1 This reduction accounts for the pharmacokinetic differences between the two insulins—many patients require twice-daily detemir dosing to achieve 24-hour coverage, whereas glargine typically provides full 24-hour coverage with once-daily administration. 5, 6

High-Risk Patient Modifications

Reduce the converted dose by 10-20% for the following populations: 1

  • Elderly patients (>65 years) 1
  • Patients with renal impairment 1
  • History of severe hypoglycemia 1
  • Poor oral intake or acute illness 1

The rationale for dose reduction in high-risk patients is the lower risk of severe hypoglycemia with glargine compared to NPH insulin (OR 0.65), though direct comparison data between detemir and glargine shows similar hypoglycemia rates. 2

Post-Conversion Monitoring Requirements

Daily fasting blood glucose monitoring is essential during the first 1-2 weeks after conversion. 1 Adjust the dose every 3 days based on fasting glucose values, targeting 80-130 mg/dL. 1

Dose adjustment algorithm: 1

  • If fasting glucose is 140-179 mg/dL: increase by 2 units every 3 days
  • If fasting glucose is ≥180 mg/dL: increase by 4 units every 3 days
  • If hypoglycemia occurs: reduce dose immediately by 10-20% and reassess

Administration Timing

Administer Lantus at the same time each day, typically with the evening meal or at bedtime. 1 This maintains consistency with the previous Levemir bedtime dosing schedule.

Common Pitfalls to Avoid

Do not dilute or mix Lantus with any other insulin or solution due to its low pH diluent. 1, 7 This is a critical safety consideration emphasized by the American Association of Clinical Endocrinologists. 1

Do not assume the conversion will be perfect—individual patient response varies. 4 While meta-analyses show no clinically significant differences in efficacy between detemir and glargine, some patients may require dose adjustments based on their glucose response. 4

Continue metformin and other non-insulin diabetes medications unless contraindicated. 8, 9 The basal insulin conversion does not necessitate changes to the foundation diabetes therapy.

Related Questions

Should Lantus (insulin glargine) be refrigerated?
What should be the dose of insulin glargine (Lantus), insulin sensitivity factor (ISF), and insulin‑to‑carbohydrate ratio (ICR) for a 45‑year‑old man weighing 98.4 kg with newly diagnosed type 2 diabetes, hemoglobin A1c 14.5%, normal renal function, not in diabetic ketoacidosis, who received insulin drip rates of 2, 2, 3, 2, 2, 3, 3, 3, and 2 units over the past 8 hours?
How to manage type 1 diabetes in an underweight patient with well-controlled overnight glucose on Lantus (insulin glargine)?
A 46-year-old woman with a current hemoglobin A1c of 6.2% (previously 11.6% nine months ago) has fasting glucose around 150 mg/dL; should she continue taking 15 units of insulin glargine (Lantus) at bedtime and 7 units of insulin lispro with each meal?
Can a 39-year-old male with diabetes who is currently on nightly insulin detemir (Levemir) 34 U be switched to insulin glargine (Lantus), and what dose of Lantus should be used?
What are the recommended non-NSAID (Non-Steroidal Anti-Inflammatory Drugs) antipyretics for patients with impaired liver function or other conditions requiring alternative fever reduction treatment?
What medications should be used to manage preload and afterload in a patient with low ejection fraction (EF) cardiogenic shock?
What are the recommended methods for sending a blood sample from a patient undergoing dialysis to minimize infection and contamination risk?
How does a patient with abdominal pain, diarrhea, and weight loss present with symptoms suggestive of inflammatory bowel disease, such as ulcerative colitis or Crohn's disease?
What does pachymeningitis on a brain MRI indicate in an adult patient with no prior medical history?
What is the preferred choice between kitchen feeds and formula feeds (such as Isocal or Osmolite) for nutrition support in a critically ill patient in the Intensive Care Unit (ICU)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.